Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CROWD-ASPECT: Spironolactone vs Eplerenone in Heart Failure
NCT03984591Phase 4Enrolling by invitation
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Nov 2020
- Primary completion
- Dec 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone, eplerenone, sponsored by Bispebjerg and Frederiksberg Hospital. Started Nov 2020; status: enrolling by invitation.
02
Drugs
spironolactoneeplerenone
Beyond the preview
Go deeper on NCT03984591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03984591.